Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation

被引:35
|
作者
Paulmann, Dajana [1 ]
Magulski, Thomas [1 ]
Schwarz, Rebecca [1 ]
Heitmann, Lisa [1 ]
Flehmig, Bertram [2 ]
Vallbracht, Angelika [1 ]
Dotzauer, Andreas [1 ]
机构
[1] Univ Bremen, Dept Virol, D-28359 Bremen, Germany
[2] Univ Tubingen, Childrens Hosp, Dept 1, D-72076 Tubingen, Germany
来源
JOURNAL OF GENERAL VIROLOGY | 2008年 / 89卷
关键词
D O I
10.1099/vir.0.83521-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis A virus (HAV) antagonizes the innate immune response by inhibition of retinoic acid-inducible gene I-mediated and melanoma differentiation-associated gene 5-mediated beta interferon (IFN-beta) gene expression. This study showed that this is due to an interaction of HAV with mitochondrial antiviral signalling protein (MAVS)-dependent signalling, in which the viral nonstructural protein 2B and the protein intermediate 3ABC recently suggested in this context seem to be involved, cooperatively affecting the activities of MAVS and the kinases TANK-binding kinase 1 (TBK1) and the inhibitor of NF-kappa B kinase epsilon (IKK epsilon). In consequence, interferon regulatory factor 3 (IRF-3) is not activated. As IRF-3 is necessary for IFN-beta transcription, inhibition of this factor results in efficient suppression of IFN-beta synthesis. This ability might be of vital importance for HAV, which is an exceptionally slow growing virus sensitive to IFN-beta, as it allows the virus to establish infection and maintain virus replication for a longer period of time.
引用
收藏
页码:1593 / 1604
页数:12
相关论文
共 50 条
  • [31] INTERFERON CONSENSUS SEQUENCE-BINDING PROTEIN, A MEMBER OF THE INTERFERON REGULATORY FACTOR FAMILY, SUPPRESSES INTERFERON-INDUCED GENE-TRANSCRIPTION
    NELSON, N
    MARKS, MS
    DRIGGERS, PH
    OZATO, K
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 588 - 599
  • [32] Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection
    Cheng, Tsu-Fan
    Rzostek, Sabrina B.
    Ando, Osamu
    Van Scoy, Sarah
    Kumar, K. Prasanna
    Reich, Nancy C.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (12): : 7462 - 7470
  • [33] Treatment with combination of PEG IFN α-2B and ribavirin suppresses viral replication in liver transplantation recipients with recurrent HCV hepatitis
    Khatib, MA
    Arenas, JI
    Carey, E
    Moss, A
    Mulligan, D
    Ortiz, L
    Hansen, K
    Harrison, ME
    Douglas, D
    Balan, V
    Rakela, J
    Vargas, HE
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [34] Interferon (IFN)-γ and Herpes simplex virus/tumor necrosis factor-α synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-κB and IFN regulatory factor-1
    Paludan, SR
    Malmgaard, L
    Ellermann-Eriksen, S
    Boscá, L
    Mogensen, SC
    EUROPEAN CYTOKINE NETWORK, 2001, 12 (02) : 297 - 308
  • [35] IDENTIFICATION OF THE HEPATITIS-B VIRUS FACTOR THAT INHIBITS EXPRESSION OF THE INTERFERON-BETA GENE
    WHITTEN, TM
    QUETS, AT
    SCHLOEMER, RH
    JOURNAL OF VIROLOGY, 1991, 65 (09) : 4699 - 4704
  • [36] Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection
    Watanabe, H
    Enomoto, N
    Nagayama, K
    Izumi, N
    Marumo, F
    Sato, C
    Watanabe, M
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (08): : 1195 - 1203
  • [37] Interpersonal interactions as an important aspect of quality of life (QOL) in hepatitis C during therapy with interferon-α-2b (IFN).
    Kraus, MR
    Schaefer, AW
    Faller, H
    Moerk, H
    Scheurlen, M
    HEPATOLOGY, 1999, 30 (04) : 198A - 198A
  • [38] Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy:: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy).
    Pimstone, NR
    Canio, JB
    Chiang, MH
    Kokosinski, J
    Powell, JS
    Saicheur, T
    Sheykhzadeh, PI
    Yu, AS
    GASTROENTEROLOGY, 2001, 120 (05) : A568 - A568
  • [39] Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2
    Testoni, Barbara
    Voellenkle, Christine
    Guerrieri, Francesca
    Gerbal-Chaloin, Sabine
    Blandino, Giovanni
    Levrero, Massimo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (23) : 20217 - 20227
  • [40] Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy
    Tanabe, Y
    Nagayama, K
    Enomoto, N
    Izumi, N
    Tazawa, J
    Kurosaki, M
    Sakamoto, N
    Sato, C
    Watanabe, M
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 251 - 261